An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab)
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This observational study will assess the execution, efficacy and safety of treatment with
MabThera in patients with rheumatoid arthritis. Data from patients receiving MabThera
according to local treatment guidelines will be collected for 29 months. Target sample size
is 100-200 patients.